CD8A and cancer: In summary, combining palmitoylated antigen and palmitoylated LeY together with a αGC in one liposome constitutes a promising peptide vaccination platform for in situ delivery to skin APCs which allows for increased uptake and antigen presentation to CD8+ T-cells together with iNKT activation and therefore may contribute to improve ICI anti-cancer immunotherapy.